These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1915595)

  • 21. Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
    Penner SB; Smyth DD; Glavin GB
    J Pharmacol Exp Ther; 1993 Jul; 266(1):339-43. PubMed ID: 8101219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a new neuropeptide Y Y5 agonist radioligand: [125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP.
    Dumont Y; Thakur M; Beck-Sickinger A; Fournier A; Quirion R
    Neuropeptides; 2004 Aug; 38(4):163-74. PubMed ID: 15337369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
    Woldbye DP; Nanobashvili A; Sørensen AT; Husum H; Bolwig TG; Sørensen G; Ernfors P; Kokaia M
    Neurobiol Dis; 2005 Dec; 20(3):760-72. PubMed ID: 15979311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a receptor protein for neuropeptide Y in rabbit kidney. G-protein association and inhibition of adenylate cyclase.
    Gimpl G; Wahl J; Lang RE
    FEBS Lett; 1991 Feb; 279(2):219-22. PubMed ID: 1848189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain.
    Widdowson PS; Halaris AE
    Brain Res; 1991 Jan; 539(2):196-202. PubMed ID: 1647239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acylation of the alpha-amino group in neuropeptide Y(12-36) increases binding affinity for the Y2 receptor.
    Murase S; Yumoto N; Petukhov MG; Yoshikawa S
    J Biochem; 1996 Jan; 119(1):37-41. PubMed ID: 8907173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro.
    Greber S; Schwarzer C; Sperk G
    Br J Pharmacol; 1994 Nov; 113(3):737-40. PubMed ID: 7858862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropeptide Y-stimulated [(35) S]GTPγs functional binding is reduced in the hippocampus after kainate-induced seizures in mice.
    Elbrønd-Bek H; Olling JD; Gøtzsche CR; Waterfield A; Wörtwein G; Woldbye DP
    Synapse; 2014 Oct; 68(10):427-36. PubMed ID: 24985894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease.
    Diez M; Koistinaho J; Dearmond SJ; Groth D; Prusiner SB; Hökfelt T
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13267-72. PubMed ID: 9371835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of neuropeptide Y binding sites in the zona glomerulosa of the bovine adrenal gland.
    Torda T; Cruciani RA; Saavedra JM
    Neuroendocrinology; 1988 Aug; 48(2):207-10. PubMed ID: 2851754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed.
    McAuley MA; Westfall TC
    J Pharmacol Exp Ther; 1992 Jun; 261(3):863-8. PubMed ID: 1351098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 125I-neuropeptide Y and 125I-peptide YY bind to multiple receptor sites in rat brain.
    Walker MW; Miller RJ
    Mol Pharmacol; 1988 Dec; 34(6):779-92. PubMed ID: 2849045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the receptors for peptide-YY and avian pancreatic polypeptide in chicken and pig brains.
    Inui A; Okita M; Miura M; Hirosue Y; Nakajima M; Inoue T; Oya M; Baba S
    Endocrinology; 1990 Aug; 127(2):934-41. PubMed ID: 2164925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of peptide YY receptors in the brain.
    Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Shii K; Yokono K; Mizuno N; Baba S
    Endocrinology; 1989 Jan; 124(1):402-9. PubMed ID: 2535812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropeptide Y (NPY) metabolism by endopeptidase-2 hinders characterization of NPY receptors in rat kidney.
    Price JS; Kenny AJ; Huskisson NS; Brown MJ
    Br J Pharmacol; 1991 Oct; 104(2):321-6. PubMed ID: 1665730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of monoiodinated neuropeptide Y to hippocampal membranes and human neuroblastoma cell lines.
    Sheikh SP; O'Hare MM; Tortora O; Schwartz TW
    J Biol Chem; 1989 Apr; 264(12):6648-54. PubMed ID: 2708330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Y1 and Y2 receptors for neuropeptide Y.
    Sheikh SP; Håkanson R; Schwartz TW
    FEBS Lett; 1989 Mar; 245(1-2):209-14. PubMed ID: 2538360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes.
    Castan I; Valet P; Voisin T; Quideau N; Laburthe M; Lafontan M
    Endocrinology; 1992 Oct; 131(4):1970-6. PubMed ID: 1327725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-function studies on neuropeptide Y and pancreatic polypeptide--evidence for two PP-fold receptors in vas deferens.
    Jørgensen JC; Fuhlendorff J; Schwartz TW
    Eur J Pharmacol; 1990 Sep; 186(1):105-14. PubMed ID: 2178092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.